Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Tseng Lab on the move? -- Ignore unavailable to you. Want to Upgrade?

To: bob who wrote (145)	7/5/1998 10:59:00 AM
From: muddphudd	Read Replies (1) \| Respond to of 251

I have read the last few posts since CPI and Tseng labs agreed to merge (pending approval). I also visited the CPI webpage. The treatment idea sounds very interesting; Initiate programmed cell death (apoptosis) of cancer cells and leave normal cells unharmed. The only problem I have at this point is that they never clearly describe HOW this is accomplished with their lead compound FGN-1. It is tough to judge the potential of this drug without knowing how it is SUPPOSED to work.